ALBERT LABS INTL. CORP.

Research ALBERT LABS INTL. CORP. (VB50) on Bullrun: market cap EUR 372.07K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerVB50
• ExchangeF
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 372.07K
• Financial periodFY2022
• Net income-EUR 7.06M
• Free cash flow-EUR 1.50M

Valuation Snapshot

latest market cap is EUR 372.07K.

About ALBERT LABS INTL. CORP.

Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada.

Frequently asked questions

What is ALBERT LABS INTL. CORP.'s market cap?

ALBERT LABS INTL. CORP.'s market capitalization is EUR 372.07K.

What does ALBERT LABS INTL. CORP. do?

Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. It develops KRN-101, is a solution for cancer-related anxiety.